Page 3 - Titanium Technologies News Today

Chemours (NYSE:CC – Get Free Report) had its price objective raised by investment analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price target points to a potential upside of 1.38% from […]

Chemours (NYSE:CC – Get Free Report) had its target price increased by research analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective would suggest a potential upside of 1.38% from […]

Chemours (NYSE:CC – Get Free Report) had its target price increased by research analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective would suggest a potential upside of 1.38% from […]

Dignam joined Chemours in 2015. She has held senior roles in the chemical industry in business and operations, sales and marketing, commercialization, and supply chain.

CC earnings call for the period ending December 31, 2023.

Celebrating Women in STEM at Chemours

The previous CEO and president had been placed on administrative leave.

29.03.2024 - NORTHAMPTON, MA / ACCESSWIRE / March 29, 2024 / The Chemours Company:Every March, Womens History Month provides a platform to honor women whose contributions to science, politics, arts, and beyond have significantly shaped our world. This year, ... Seite 1

The previous CEO and president had been placed on administrative leave.

Chemours reported its 2023 4th-quarter earnings Wednesday and continues to deal with an internal audit review.